Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
72.48
-0.07 (-0.10%)
Mar 31, 2025, 10:13 AM EDT - Market open

Globus Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
2,5191,5681,023958.1789.04
Upgrade
Revenue Growth (YoY)
60.62%53.34%6.76%21.43%0.47%
Upgrade
Cost of Revenue
819.88476.52262.83239.22217.46
Upgrade
Gross Profit
1,6991,092760.01718.88571.58
Upgrade
Selling, General & Admin
977.48643.41432.12408.15354.76
Upgrade
Research & Development
161.6124.0173.0297.3584.52
Upgrade
Operating Expenses
1,258818.45522.87524.02456.11
Upgrade
Operating Income
441.03273.51237.15194.86115.47
Upgrade
Interest Expense
-4.19----
Upgrade
Interest & Investment Income
-20.1314.239.313.95
Upgrade
Currency Exchange Gain (Loss)
-43.2914.26-1.02-1.42-0.28
Upgrade
Other Non Operating Income (Expenses)
1.57-1.357.243.361.38
Upgrade
EBT Excluding Unusual Items
395.12306.55257.6206.09130.53
Upgrade
Merger & Restructuring Charges
-274.72-139.93-6.85-16.98-4.03
Upgrade
Gain (Loss) on Sale of Investments
0.64-0.79-5.39-2.78-0.59
Upgrade
Legal Settlements
-0.31-0.43-2.34-5.92-0.01
Upgrade
Pretax Income
120.72165.39243.02180.41125.9
Upgrade
Income Tax Expense
17.7442.5252.8531.2223.61
Upgrade
Net Income
102.98122.87190.17149.19102.29
Upgrade
Net Income to Common
102.98122.87190.17149.19102.29
Upgrade
Net Income Growth
-16.19%-35.39%27.47%45.86%-34.10%
Upgrade
Shares Outstanding (Basic)
13611310010199
Upgrade
Shares Outstanding (Diluted)
138115103104101
Upgrade
Shares Change (YoY)
20.27%11.68%-0.95%2.63%-1.01%
Upgrade
EPS (Basic)
0.761.091.891.481.04
Upgrade
EPS (Diluted)
0.751.071.851.441.01
Upgrade
EPS Growth
-29.91%-42.16%28.47%42.57%-33.55%
Upgrade
Free Cash Flow
405.21165.23104.42219.38135.14
Upgrade
Free Cash Flow Per Share
2.941.441.022.121.34
Upgrade
Gross Margin
67.46%69.62%74.30%75.03%72.44%
Upgrade
Operating Margin
17.51%17.44%23.18%20.34%14.63%
Upgrade
Profit Margin
4.09%7.83%18.59%15.57%12.96%
Upgrade
Free Cash Flow Margin
16.08%10.53%10.21%22.90%17.13%
Upgrade
EBITDA
695.05418.24305.4264.73178.35
Upgrade
EBITDA Margin
27.59%26.66%29.86%27.63%22.60%
Upgrade
D&A For EBITDA
254.02144.7368.2569.8762.87
Upgrade
EBIT
441.03273.51237.15194.86115.47
Upgrade
EBIT Margin
17.51%17.44%23.18%20.34%14.63%
Upgrade
Effective Tax Rate
14.69%25.71%21.75%17.30%18.76%
Upgrade
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q